Article ID Journal Published Year Pages File Type
4026093 Ophthalmology 2014 12 Pages PDF
Abstract
These phase 3 trials demonstrated that ranibizumab treatment for DME likely improves patient-reported vision-related function outcomes compared with sham, further supporting treatment of DME with ranibizumab.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Ophthalmology
Preview
Vision-Related Function after Ranibizumab Treatment for Diabetic Macular Edema
Authors
, , , , , , , , , ,